Postinfarction exercise capacity after lidoflazine treatment or physical training

Area of Science:

• Cardiology
• Exercise Physiology
• Pharmacology

Background:

• Postinfarction patients often experience reduced cardiovascular function and exercise capacity.
• Physical training is a known intervention to improve cardiovascular adaptation in these patients.
• Pharmacological interventions are being explored to complement or provide alternatives to exercise training.

Purpose of the Study:

• To compare the cardiovascular adaptation effects of lidoflazine with physical training in male postinfarction volunteers.
• To investigate whether lidoflazine improves exercise capacity and peripheral oxygen utilization.
• To assess the impact of a novel anti-anginal drug, lidoflazine, on cardiac function post-myocardial infarction.

Main Methods:

• A study involving 44 male postinfarction volunteers divided into four groups.
• Two groups underwent a 2-month physical training program (n=12) or served as controls (n=12).
• Two groups participated in a 10-month double-blind crossover study of lidoflazine (240 mg/day) versus placebo (n=10 each).

Main Results:

• Lidoflazine treatment (5 months) increased maximal exercise capacity.
• Both lidoflazine and physical training decreased heart rate during submaximal exercise.
• Stroke volume increased during submaximal exercise with both interventions, compensating for heart rate reduction.
• Lidoflazine did not improve peripheral oxygen consumption, unlike physical training.

Conclusions:

• Lidoflazine demonstrates cardiovascular adaptation benefits comparable to physical training in postinfarction patients regarding exercise capacity and cardiac hemodynamics.
• Lidoflazine's mechanism differs from physical training as it does not enhance peripheral oxygen utilization.
• Lidoflazine shows potential as a therapeutic agent for improving cardiovascular performance in postinfarction individuals.